2882 SAND HILL ROAD, MENLO PARK, CA
Makes $2 Billion Strategic Equity Investment in Summit Therapeutics
Investor Presentation
Summit Therapeutics Enters $380M Distribution Agreement with J.P. Morgan
Q2
Q1
FY 2024
Q3
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
S-3ASR
Registration Statement for Securities to be Offered to Employees
Notice of Exempt Offering of Securities
PRE 14A
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Submission Upload
Correspondence